Anonymous
Guest
Anonymous
Guest
Of course the Pfizer premium is dropping our stock price, that is the only reason it went up. AZ has not done a thing to justify an 80 or even 60 share price.
On the diabetes side we have Twice the number of reps and 3 time the number of managers needed. This jackass Topher came along and just gave managers less reps to baby sit.
The easiest way to drive up our share would be big cutbacks in sales force.
It was stupid to split up the diabetes reps to begin with, and now they aren't going to fill all those jobs identified in the reallocation. BUT WE STILL HAVE THE SAME NUMBER OF MANAGERS WITH VERY FEW REPS EACH, some with only 5-8 reps in a smaller geography than they had before. Just what the bloody hell do they even do other than talk on the phone and listen to web casts and conference calls??